News
Moderna's new COVID-19 vaccine mNexspike approved by FDA, but there's a limit on who can use it
The FDA's approval was based on a study of 11,400 people age 12 and older that compared the new low-dose vaccine with Moderna's existing vaccine. It found the new vaccine was safe and was at least as effective - and more by some measures - than the original shot, the company said.
But in 2024, there was a prolonged summer surge in California that lasted from June through the end of September. After that ...
Makary was accurate when he said that "most countries have stopped recommending" routine COVID-19 vaccination for children.
The US Centers for Disease Control and Prevention has updated its immunization schedule for children, days after US Health ...
The Centers for Disease Control and Prevention now says that kids with no underlying health conditions "may receive" COVID-19 ...
Health Secretary Robert F. Kennedy Jr. recently announced more key changes to the CDC recommendations for COVID-19 ...
Insurance coverage typically follows federal recommendations, so anyone who is healthy and under 65 is likely to have to pay ...
Health Secretary Robert F. Kennedy Jr. said on Tuesday that the vaccine would no longer appear on the childhood immunization ...
As influenza cases continue to rise in the lead up to winter, a new study has found that getting a COVID-19 booster at the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback